This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Credit: Yen Strandqvist/Chalmers The environmental effects of agriculture and food...
Two years ago, Accent Therapeutics got off a $40 million series A to target RNA-modifying...
Update (02/04/2020): The FDA has concluded an investigation into a data manipulation...
Credit: Jennifer McCann/Penn State A new way to deliver therapeutic proteins inside...
The Swedish synthetic biology company EnginZyme has raised a Series A funding round...